Genmab | GEN - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Almirall EUR 235.53M 22.52M 2026-06
Amarin USD 18.8M 29.36M 2026-06
Amgen USD 2.86B 16.65B 2026-06
argenx SE USD 719M 164.73M 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Bayer EUR 6.39B 192M 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Demant DKK 1.06B 134M 2026-06
Exelixis USD 39.06M 14.91M 2026-06
Fresenius Medical Care EUR 891.84M 1.41M 2026-06
Genmab DKK 116M 110M 2026-06
GlaxoSmithKline GBP 14.34B 7M 2026-06
GN Store Nord DKK 1.08B 69M 2026-06
GRIFOLS EUR 1B 160M 2026-06
Hikma Pharmaceutical USD 715M 104M 2025-12
Insmed USD 74.55M 1.18M 2026-06
Lakefront Biotherapeutics EUR 66.35M 29.42M 2026-06
Lonza CHF 471M 3M 2024-12
Merck EUR 2.07B 61M 2026-06
Novartis USD 4.26B 64M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 23.6B 888M 2026-06
UCB EUR 4.04B 755M 2025-12